Salon | FDA grants Plan B exclusive marketing rights Salon The Food and Drug Administration on Tuesday granted Teva Pharmaceuticals, the manufacturer of Plan B One-Step, exclusive marketing rights for the next three years, meaning there will be no low-cost, generic versions of levonorgestrel-based emergency ... |
↧
FDA grants Plan B exclusive marketing rights - Salon
↧